Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation

Clinical Transplantation

Volumn 26, Issue 2, 2012, Pages 322-327

  Nixon, Jennifer L ^a,b   Kfoury, Abdallah G ^a,b,c   Brunisholz, Kim ^a,b   Horne, Benjamin D ^a,c   Myrick, Craig ^d   Miller, Dylan V ^a,b   Budge, Deborah ^a,b   Bader, Feras ^b,c   Everitt, Melanie ^b,e   Saidi, Abdulfattah ^c   Stehlik, Josef ^b,c   Schmidt, Tracy C ^d   Alharethi, Rami ^a,b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b Utah Transplantation Affiliated Hospitals UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Intermountain Donor Services   (United States)

^e PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Cardiac transplantation; Donor selection; Dopamine

Indexed keywords

DOPAMINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HEART MUSCLE NECROSIS; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE; VENTILATOR;

ADOLESCENT; ADULT; BRAIN DEATH; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; DOPAMINE; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NECROSIS; POSTOPERATIVE COMPLICATIONS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; YOUNG ADULT;

EID: 84859861129     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01504.x     Document Type: Article

References (15)

1. Zaroff JG, Rosengard BR, Armstrong WF et al. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation 2002: 106: 836.
2. Bittner HB, Kendall SWH, Chen EP, Van Trigt P. The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. J Heart Lung Transplant 1996: 15: 764.
3. Cooper DKC, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989: 71: 261.
4. Herijgers P, Borgers M, Flameng W. The effect of brain death on cardiovascular function in rats. Part I. Is the heart damaged? Cardiovasc Res 1998: 38: 98.
5. Salim A, Martin M, Brown C, Belzberg H, Rhee P, Demetriades D. Complications of brain death: frequency and impact on organ retrieval. Am Surg 2006: 72: 377.
6. Szabo G, Sebening C, Hackert T et al. Effects of brain death on myocardial function and ischemic tolerance of potential donor hearts. J Heart Lung Transplant 1998: 17: 921.
7. Baroldi G, Di Pasquale G, Silver MD, Pinelli G, Lusa AM, Fineschi V. Type and extent of myocardial injury related to brain damage and its significance in heart transplantation: a morphometric study. J Heart Lung Transplant 1997: 16: 994.
8. Bruinsma GJ, Nedergoff MGJ, Van De Kolk CWA et al. Bio-energetic response of the heart to dopamine following brain death-related reduced myocardial workload: a phosphorous-31 magnetic resonance spectroscopy study in the cat. J Heart Lung Transplant 1999: 18: 1189.
9. Wilhelm MJ, Pratschke J, Laskowski IA, Paz DM, Tilney NL. Brain death and its impact on the donor heart - lessons from animal models. J Heart Lung Transplant 2000: 19: 414.
10. Ullah S, Zabala L, Watkins B, Schmitz ML. Cardiac organ donor management. Perfusion 2006: 21: 93.
11. Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med 2004: 351: 2730.
12. Shivalkar B, Van Loon J, Wieland W et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993: 87: 230.
13. Silva JA, Chamorro C, Romera MA, Pardo C, Marquez J, Ortega A. High doses of catecholamines in heart donor is not associated with early graft failure in recipient. Intensive Care Med 2002: 28(Suppl): S66.
14. Lima B, Rajagopal K, Petersen RP et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation 2006: 114(Suppl 1): I27.
15. Santise G, D'Ancona G, Falletta C et al. Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation. Interact Cardiovasc Thorac Surg 2009: 9: 476.